ASX/NASDAQ Releases - News - Novogen


	Overview

	History

	Business Strategy

	Corporate Governance

	Directors


	Overview

	Technology Platform

	Pharmaceutical Drug Development

	Consumer Health


	Open Consumer Health Website


	Overview

	The Technology

	Drug Development

	Oncology Program

	Cardiovascular Program

	Dermatological Program

	Anti-inflammatory Program


	ASX/NASDAQ Releases

	Press Releases / Current News

	Boardroom Radio

	Newsletter

	Archive


	Shares

	How To Invest

	Annual reports

	Presentations

	Analysts Reports


	Offices

	Investor Contacts

	Media Contacts

	Clinical Trials


	Wednesday, 8 September 2010 Novogen agrees to sell its Intellectual Property Portfolio to its subsidiary Marshall Edwards More news

ASX Releases


Presentations made at the 2007 AGM can be listened to online. Listen to the Annual General Meeting presentations online. Click here to start the interview broadcast

About Novogen | Knowledge Base | Consumer Health | Pharmaceuticals | News | Investor Relations | Contact | Site Map
Copyright © 2010 Novogen The world leader in isoflavone research - with products including Promensil and Trinovin | Web Design by Newgency